JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-Infected Patients Without Cirrhosis: OMEGA-1

on behalf of the OMEGA-1 study team, Stefan Zeuzem, Stefan Bourgeois, Susan Greenbloom, Maria Buti, Alessio Aghemo, Pietro Lampertico, Ewa Janczewska, Seng Gee Lim, Christophe Moreno, Peter Buggisch, Edward Tam, Chris Corbett, Wouter Willems, Leen Vijgen, Bart Fevery, Sivi Ouwerkerk-Mahadevan, Oliver Ackaert, Maria Beumont, Ronald KalmeijerRekha Sinha, Michael Biermer

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-Infected Patients Without Cirrhosis: OMEGA-1'. Together they form a unique fingerprint.

Medicine & Life Sciences